RxNorm Semantic Concepts Index - 156
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "156".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 1560060 | Parakeet feathers specific IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1560060 | Parakeet feathers specific IgE | Designated preferred name (PT) | NO | |
| RxCUI: 1560060 | Parakeet feathers specific IgE | Full form of descriptor (FN) | NO | |
| RxCUI: 1560145 | Zofenoprilat arginine | Designated preferred name (PT) | NO | |
| RxCUI: 1560145 | Zofenoprilat arginine | Full form of descriptor (FN) | NO | |
| RxCUI: 1560255 | CYP3A4 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1560255 | CYP3A4 | Designated preferred name (PT) | NO | |
| RxCUI: 1560255 | CYP3A4 | Full form of descriptor (FN) | NO | |
| RxCUI: 1560374 | Product containing saroglitazar (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 1560374 | Product containing saroglitazar (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 1560374 | Product containing saroglitazar (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 1560374 | Product containing saroglitazar (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 1560426 | Substance with bradykinin B2 inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1560426 | Substance with bradykinin B2 inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1560426 | Substance with bradykinin B2 inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1560426 | Substance with bradykinin B2 inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1560426 | Substance with bradykinin B2 inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 156075 | vanillylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1561084 | Hepatitis A virus immunoglobulin M antibody | Designated preferred name (PT) | NO | |
| RxCUI: 1561084 | Hepatitis A virus immunoglobulin M antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1561084 | Hepatitis A virus immunoglobulin M antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 156235 | Dioxyline | Designated preferred name (PT) | NO | |
| RxCUI: 156235 | Dioxyline | Full form of descriptor (FN) | NO | |
| RxCUI: 156240 | ethylnorepinephrine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 156240 | ethylnorepinephrine | Designated preferred name (PT) | NO | |
| RxCUI: 156240 | ethylnorepinephrine | Full form of descriptor (FN) | NO | |
| RxCUI: 1562551 | CYP2C19 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1562551 | CYP2C19 | Designated preferred name (PT) | NO | |
| RxCUI: 1562551 | CYP2C19 | Full form of descriptor (FN) | NO | |
| RxCUI: 1563285 | Tissue transglutaminase immunoglobulin A antibody | Designated preferred name (PT) | NO | |
| RxCUI: 1563285 | Tissue transglutaminase immunoglobulin A antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1563285 | Tissue transglutaminase immunoglobulin A antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 156348 | Promethestrol | Designated preferred name (PT) | NO | |
| RxCUI: 156348 | Promethestrol | Full form of descriptor (FN) | NO | |
| RxCUI: 156348 | Promethestrol | Designated preferred name (PT) | NO | |
| RxCUI: 156348 | Promethestrol | Full form of descriptor (FN) | NO | |
| RxCUI: 156348 | Promethestrol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 15648 | 5-aminovalerate aminotransferase | Designated preferred name (PT) | NO | |
| RxCUI: 15648 | 5-aminovalerate aminotransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 15657 | 5 azadeoxycytidine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 15657 | 5 azadeoxycytidine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 15657 | 5 azadeoxycytidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 15657 | 5 azadeoxycytidine | Designated preferred name (PT) | YES | |
| RxCUI: 15657 | 5 azadeoxycytidine | Full form of descriptor (FN) | YES | |
| RxCUI: 15657 | 5 azadeoxycytidine | Designated preferred name (PT) | YES | |
| RxCUI: 15657 | 5 azadeoxycytidine | Full form of descriptor (FN) | YES | |
| RxCUI: 156632 | Ambuphylline | Designated preferred name (PT) | NO | |
| RxCUI: 156632 | Ambuphylline | Full form of descriptor (FN) | NO | |
| RxCUI: 1567428 | Substance with estrogen receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1567428 | Substance with estrogen receptor antagonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1567428 | Substance with estrogen receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 156762 | butethamate citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |